Inhalis Therapeutics is a company headquartered in Switzerland.
Inhalis Therapeutics develops inhaled drug formulations and delivery technologies to treat idiopathic pulmonary fibrosis and other serious respiratory diseases. The company is based in Lugano, Switzerland.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.